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Abstract
Background: Synaptic defects represent a major mechanism underlying altered brain functions of patients
suffering Alzheimer’s disease (AD) [1-3]. An increasing body of work indicates that the oligomeric forms of
b-amyloid (Ab) molecules exert profound inhibition on synaptic functions and can cause a significant loss of
neurotransmitter receptors from the postsynaptic surface, but the underlying mechanisms remain poorly
understood. In this study, we investigated a potential contribution of mitochondria to Ab inhibition of AMPA
receptor (AMPAR) trafficking.
Results: We found that a brief exposure of hippocampal neurons to Ab oligomers not only led to marked removal
of AMPARs from postsynaptic surface but also impaired rapid AMPAR insertion during chemically-induced synaptic
potentiation. We also found that Ab oligomers exerted acute impairment of fast mitochondrial transport, as well as
mitochondrial translocation into dendritic spines in response to repetitive membrane depolarization. Quantitative
analyses at the single spine level showed a positive correlation between spine-mitochondria association and the
surface accumulation of AMPARs. In particular, we found that spines associated with mitochondria tended to be
more resistant to Ab inhibition on AMPAR trafficking. Finally, we showed that inhibition of GSK3b alleviated Ab
impairment of mitochondrial transport, and effectively abolished Ab-induced AMPAR loss and inhibition of AMPAR
insertion at spines during cLTP.
Conclusions: Our findings indicate that mitochondrial association with dendritic spines may play an important role
in supporting AMPAR presence on or trafficking to the postsynaptic membrane. Ab disruption of mitochondrial
trafficking could contribute to AMPAR removal and trafficking defects leading to synaptic inhibition.
Background
Alzheimer’s disease (AD) often attacks aged populations
and is highlighted by progressive loss of memory and
cognitive abilities [4]. AD brains exhibit two major
pathological hallmarks: extracellular senile plaques con-
taining b-amyloid aggregates and intracellular neurofi-
brillary tangles consisting of hyperphosphorylated
microtubule-associated tau proteins [5,6]. b-amyloid
(Ab) molecules are generated by proteolytic cleavage of
the transmembrane b-amyloid precursor protein (APP)
[7,8]. Aggregated Ab fibrils constitute the core of neuri-
tic plaques and are believed to be a major culprit
for neurodegeneration and subsequent cognitive
abnormalities in AD patients [9-11]. Recent studies,
however, indicate that Ab molecules exert adverse
effects on neuronal functions independent of cell death.
Specifically, soluble Ab oligomers were found to exert
severe inhibition of synaptic functions and plasticity
[1,12-14], including impairment of long-term potentia-
tion (LTP) and facilitation of long-term depression
(LTD) of central synapses [15,16]. Therefore, a better
understanding of Ab inhibition of synaptic functions
would provide significant insights into the AD neuro-
pathogenic process, potentially leading to better strate-
gies for prevention and treatment of AD.
A major mechanism to modify synaptic strength is to
alter the number, types, or properties of neurotransmit-
ter receptors at the postsynaptic terminal [17-20]. The
major ionotropic glutamate receptors involved in
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hydroxy-5-methyl-4-isoxazolepropionic acid receptors
(AMPARs) and N-methyl D-aspartate receptors
(NMDARs). AMPARs are best studied for their rapid
trafficking into and out of the synapse by cycling
between intracellular stores and the cell surface during
synaptic potentiation and depression, respectively
[19-22]. NMDARs, due to their voltage-dependent
blockade by Mg
2+, are thought to function as a coinci-
dence detector of presynaptic and postsynaptic firing
and act as the trigger of LTP. It has been shown that
activity-dependent trafficking of NMDARs also plays an
important role in synaptic plasticity and its alteration
may contribute to neuropsychiatric disorders [23]. There
is an increasing body of evidence to show that Ab mole-
cules, especially soluble Ab oligomers, exert a negative
impact on glutamate receptor trafficking in central
synapses, leading to synaptic deficits. For example, solu-
ble Ab oligomers have been shown to bind to AMPARs
[24] or NMDARs [25] to cause their internalization,
leading to inhibition of LTP and synaptic activity. How-
ever, the precise cellular mechanisms underlying Ab
effects on glutamate receptors remain to be elucidated.
Mitochondria are a vital organelle involved in many, if
not all, functions of cells. Not only are mitochondria the
main energy source of the cell, but they also serve as a
part of intracellular Ca
2+ stores and regulate intracellu-
lar Ca
2+ homeostasis, and most importantly regulate cell
apoptosis [26-29]. Mitochondria are mostly produced in
the cell body and transported to specific cellular loca-
tions of increased energy needs such as synapses. It is
clear that synaptic transmission and remodeling require
localized mitochondria to generate ATP as well as to
control local Ca
2+ concentrations [30,31]. While mito-
chondria are known to accumulate at the presynaptic
terminal for neurotransmitter release[32], localization of
mitochondria to the postsynaptic terminals has also
been demonstrated [33]. Our previous study showed
that soluble Ab molecules acutely impair mitochondrial
movement in cultured hippocampal neurons [34]. We
thus speculated that disruption of mitochondrial locali-
zation to synapses may exert adverse effects on synaptic
functions. In this study, we utilized live-cell imaging to
investigate whether soluble Ab oligomers adversely
affect AMPAR trafficking at the postsynaptic terminal
and its potential mitochondrial connection. We show
that soluble Ab oligomers caused acute reduction of
AMPARs on the spine surface and impaired AMPAR
insertion during chemically-induced LTP. Furthermore,
Ab oligomers rapidly impaired mitochondrial transport
and translocation into dendritic spines. Our analyses
revealed that mitochondrial localization to spines is
positively correlated to the presence/insertion of
AMPARs on the spine surface. Finally, inhibition of
GSK3b prevented Ab inhibition of both mitochondrial
transport and AMPAR trafficking. Together, these find-
ings indicate that mitochondrial localization to dendritic
spines may be important for AMPAR trafficking and
acute Ab impairment of mitochondrial trafficking could
contribute to the adverse effects of Ab on AMPARs at
synapse.
Results
Ab oligomers decrease surface AMPARs and inhibit TEA
induced surface AMPAR increase at dendritic spines
We took advantage of pH-dependent fluorescence emis-
sion of pHluorin molecules and expressed a super-eclip-
tic pHluorin fused to the N-terminus of the AMPAR
glutamate receptor 1 (SEP-GluR1) in cultured hippo-
campal neurons for live-cell imaging of AMPAR traffick-
ing. The strong fluorescence of SEP at pH ≥ 7.0 (e.g.
extracellular solution: pH 7.4) allowed us to detect the
surface presence and dynamic changes of SEP-GluR1 at
t h es i n g l es p i n el e v e l[ 3 5 , 3 6 ] .W ef o u n dt h a tS E P -
GluR1-expressing neurons exhibited numerous spines
along the dendritic processes, many of which exhibited
strong SEP-GluR1 fluorescence (Figure 1a, also see Fig-
ure S1 in Additional file 1). On the other hand, the den-
dritic shaft, as well as a substantial number of the
spines, displayed a low level of diffuse SEP-GluR1 fluor-
escence, which was considered as the background sig-
nals of unclustered SEP-GluR1. These imaging data are
consistent with the notion that spines represent the
postsynaptic terminals of excitatory synapses with con-
centrated glutamate receptors. We confirmed that the
strong SEP-GluR1 fluorescence came from surface SEP-
GluR1 as it was effectively quenched by cell-imperme-
able acidic buffer (Additional file 1, Figure S1).
Recent studies have shown that long term exposure to
Ab oligomers decreases synaptic AMPAR number and
impairs AMPAR trafficking [24,37]. We therefore tested
if Ab oligomers exert any acute effects on surface
AMPARs. We prepared an oligomeric Ab solution (Ab-
O, see Methods) and western blotting confirmed the
presence of dimers and trimers, as well as monomers
(Figure 1b). Based on the western blot, the amount of
oligomers (dimers and trimers) is less than 10% of the
monomers in this Ab preparation. We found that a 30
min exposure of hippocampal neurons to 5 μMA b-O
(<500 nM oligomers, based on the western blot) resulted
in a marked loss of surface SEP-GluR1 at numerous
spines (lower panels in Figure 1a, arrows; see also Figure
S2 in Additional file 1), whereas similar exposure to a
control saline (HBS) had no effect (upper panels in Fig-
u r e1 a ;s e ea l s oF i g u r eS 2i nA d d i t i o n a lf i l e1 ) .W e
quantified the numbers of spines exhibiting SEP-GluR1
fluorescence before and after 30 min treatment using an
intensity threshold that cut off the baseline fluorescence
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tional file 1). Our results show that Ab-O resulted in
~40% reduction in the number of spines emitting strong
SEP-GluR1 fluorescence, while the total number of
spines was not changed (Figure 1c). To test if Ab oligo-
mers were the ones affecting AMPARs, we prepared an
Ab solution containing only monomers (Ab-M; Figure
1b). Our data showed that Ab monomers had no effect
on SEP-GluR1 signals at dendritic spines (Figure 1c),
confirming the notion that Ab monomers do not affect
neuronal viability and functions [1,38]. Together, our
data show that Ab oligomers in submicromolar concen-
tration markedly reduce surface AMPARs at postsynap-
tic terminals.
To study the influence of Ab oligomers on AMPAR
trafficking during synaptic plasticity, we adopted a
method to chemically induce LTP (cLTP) by a brief
exposure of cells to a potassium channel blocker tetra-
ethylammonium (TEA), which has been shown to
robustly elicit AMPAR-dependent LTP in brain slices
[39]. We exposed mature (DIV21) hippocampal neurons
expressing SEP-GluR1 to 25 mM TEA in a high-calcium
Figure 1 Ab-induced loss of surface AMPARs as revealed by confocal live-cell imaging of SEP-GluR1.( a)R e p r e s e n t a t i v ei m a g e so f
dendritic regions of cultured hippocampal neurons (DIV21) expressing SEP-GluR1 before and after 30 min exposure to the control saline (HBS,
upper panels) or 5 μMA b1-42 solution (lower panels). SEP-GluR1 signals are mostly seen concentrating in dendritic spines. Arrows indicate the
spines exhibiting substantial loss of SEP-GluR1 signals after 30 min exposure to Ab. Scale bar: 10 μm. (b) Western blots showing the existence of
Ab monomers and oligomers in our Ab preparation. Two different exposures (+ short, +++ long) were shown to ensure that no additional Ab
aggregates in Ab-M and Ab-O preparations. (c) Quantitative analysis showing the number of total spines or spines exhibiting strong SEP-GluR1
fluorescence after 30 min exposure to HBS or Ab. The data were normalized against the number before the 30 min exposure with 100%
indicating no change. Triple asterisks: p < 0.0005 comparing to the corresponding control group (Student’s t-test).
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ined changes in SEP-GluR1 fluorescence at spines. The
potentiation of synaptic effi c a c yb yt h i sc L T Pm e t h o d
was confirmed by whole cell patch-clamp recording of
both spontaneous and miniature excitatory postsynaptic
currents (Additional file 1, Figure S3). We found that a
10 min TEA exposure resulted in a marked increase in
the number of spines exhibiting strong SEP-GluR1
fluorescence (Figure 2a, arrows; see also Figure S1 in
Additional file 1). Quantification of the number of
spines exhibiting bright SEP-GluR1 fluorescence before
and after cLTP showed about 30% increase, whereas the
control saline did not cause any changes (Figure 2b).
Pre-treatment of neurons with 5 μMA b-O for 30 min
eliminated TEA-induced increase in spines exhibiting
bright SEP-GluR1 fluorescence (Figure 2b). Therefore,
Ab oligomers inhibited AMPAR insertion during synap-
tic potentiation.
Ab oligomers acutely inhibit mitochondria trafficking
Many mitochondria in neurons display microtubule-
dependent fast movement in both axonal and dendritic
processes, which could be acutely impaired by soluble
Ab molecules [34,40]. Here we further confirmed that
the oligomeric form of Ab exerted acute impairment of
fast mitochondrial movement in hippocampal neurons
(Figure 3), whereas Ab m o n o m e r sh a dn oe f f e c t( A d d i -
tional file 1, Figure S4). Mitochondria also translocate
into dendritic protrusions (filopodia and spines) in
response to neuronal activity, which may play a role in
Figure 2 Ab inhibition of AMPAR insertion during chemical LTP.( a) Representative images showing the increase of SEP-GluR1 elicited by 10
min TEA treatment with (bottom pair) and without (top pair) 30 min exposure to Ab oligomers. (b) Quantification of the number of spines
exhibiting strong SEP-GluR1 fluorescence after 10 min exposure to either HBS (control) or 25 mM TEA with and without Ab treatment. The data
were normalized against the number before 10 min exposure to either HBS or TEA with 100% indicating no change. Triple asterisks: p < 0.0005
comparing to the HBS control (Student’s t-test).
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ined if Ab oligomers also inhibit activity-dependent
mitochondrial translocation into dendritic spines. Con-
sistently, we found that repetitive KCl depolarization
caused a significant increase in the number of spines
containing mitochondria (Figure 4a). Quantitative analy-
sis showed that the number of spines containing mito-
chondria almost doubled after repetitive KCl treatment
(Figure 4b). However, 30 min exposure of the neurons
to 5 μMA b-O completely blocked the increase of mito-
chondrial translocation into spines by repetitive KCl
depolarization (Figure 4b). Repetitive exposure of neu-
rons to the control saline (KRB) with and without Ab-O
in bath did not affect the number of spines containing
mitochondria with and without Ab presence. Therefore,
Ab oligomers appear to impair fast mitochondrial move-
ment as well as trafficking to postsynaptic terminals in
response to membrane depolarization.
Ab inhibition of surface AMPAR trafficking: a potential
mitochondrial contribution
Given that Ab oligomers similarly inhibited trafficking
of both AMPARs and mitochondria, we hypothesized
that a close localization/association of mitochondria to
spines may be important for the maintenance of
AMPARs on the spine surface, as well as for their
increase during synaptic potentiation. To test this
hypothesis, we performed extensive analysis on the
association of mitochondria with spines exhibiting
strong SEP-GluR1 fluorescence or ones with weak fluor-
escence similar to that of dendritic shaft. We hereafter
referred to these two types of spines as bright and dim
spines, respectively, for our analysis. Here, hippocampal
neurons expressing both SEP-GluR1 and Mito-mOrange
were examined by live-cell confocal imaging. Merged
color images of SEP-GluR1 and Mito-mOrange show
that many spines, especially those bright spines, have
mitochondria positioned nearby (Figure 5a). To analyze
spine-mitochondria association, we developed a scoring
system to give each spine a spine-mito score (Figure
5a): 3 = mitochondria inside the spine, 2 = mitochon-
dria in dendritic shaft but spanning across the entire
spine base, 1 = mitochondria in dendritic shaft only
partially covering the spine base or immediately adja-
cent to the spine, 0 = no mitochondria in the vicinity of
at least two-spine distance. Our analysis of several hun-
dreds spines showed that, at baseline, bright spines had
a significant higher spine-mito score than dim spines
Figure 3 Acute impairment of mitochondrial movement by Ab oligomers as revealed by time-lapse imaging of Mito-DsRed expressing
neurons.( a) Representative images of a hippocampal neuron expressing Mito-DsRed (red), which was also stained by MitoTracker (green). The
merged image (the 3
rd panel) shows that Mito-DsRed and MitoTracker signals are perfectly colocalized in this transfected neuron, whereas
MitoTracker also labeled many more mitochondria in surrounding cells. (b) Representative images from time-lapse sequences before and after 30
min exposure to Ab1-42 oligomers. The left panels represent a snapshot of the mitochondrial distribution in a Mito-DsRed-expressing neuron. The
right panels represent the movement traces of mitochondria derived from 5-min time-lapse sequences. The movement traces were generated
from the time-lapse sequence using Zprojection followed by division against the first frame using ImageJ software [34]. (c) Quantitative analysis
showing the number of moving mitochondria after 30 min treatment with the control saline and different concentration of Ab-O. The data were
normalized against the number of moving mitochondria before the 30 min treatment with 100% indicating no change. Triple asterisks:
p < 0.0005 (comparing to vehicle, Student’s t-test).
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spines associated with mitochondria (spines with spine-
mito scores of 1-3) and found that, consistently, more
bright spines were associated with mitochondria than
dim spines (Figure 5c). These results suggest that mito-
chondrial association with spines may favor surface pre-
sence of AMPARs in spines.
Using the same analysis, we next examined the loss of
surface AMPARs induced by acute Ab-O exposure.
Both the spine-mito score and the percentage of spines
associated with mitochondria showed a significant dif-
ference between bright spines that lost SEP-GluR1 sig-
nals and those exhibited no change under Ab-O
exposure (Figure 5b &5c). Generally, spines exhibiting
SEP-GluR1 loss had a lower spine-mito score and less
mitochondrial association than those without loss. We
next performed similar analysis on the potential associa-
tion of mitochondria with spines exhibiting AMPAR
insertion during cLTP. We found that dim spines
exhibiting marked increase in SEP-GluR1 fluorescence
had a higher spine-mito score and more mitochondrial
association than those without SEP-GluR1 increase (Fig-
ure 5b &5c). Taken together, these data suggest that
spines associated with mitochondria tend to favor
AMPAR insertion during cLTP and appear to be more
resistant to AMPAR loss induced by Ab oligomers.
Glycogen synthase kinase-3b (GSK3b)i sk n o w nt o
play an important role in Ab toxicity [41-43] and our
previous study showed that inhibition of GSK3b alle-
viated Ab impairment of mitochondrial transport [34].
We hence tested if GSK3b inhibition could also mitigate
Ab inhibition of AMPAR trafficking. Using a specific
GSK3b inhibitor SB415286 [44,45], we found that both
Ab-induced loss of AMPARs and inhibition of AMPAR
insertion during cLTP were largely abolished (Figure 6).
These data thus suggest a potentially shared pathway for
Ab impairment of mitochondrial transport and AMPAR
trafficking. Taken together, our results suggest that
Figure 4 Ab impairment of mitochondrial trafficking into spines in response to repetitive KCl depolarization.( a) Representative images
of dendritic segments of hippocampal neurons expressing GFP and Mito-DsRed before and after repetitive KCl depolarization (4X), with (lower
pair) and without (upper pair) 30 min exposure to Ab oligomers. Arrows indicate spines containing mitochondria after the repetitive KCl
depolarization. Scale bar: 10 μm. (b) Quantification of the number of spines containing mitochondria after repetitive exposure (4 times) to either
KRB (control) or KCl, with and without Ab treatment. The data are normalized against the number of spines before the repetitive exposure with
100% indicating no change. Triple asterisks: p < 0.0005 compared to the control (Student’s t-test).
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be important for the maintenance of surface AMPARs
at spines at the resting state and their increase during
plasticity. Acute impairment of mitochondrial trafficking
by Ab oligomers could potentially contribute to or
accelerate Ab-induced loss of surface AMPAR and inhi-
bition of AMPAR insertion during synaptic potentiation.
Discussion
Soluble Ab oligomers have been shown to impair synap-
tic functions but the underlying mechanisms remain to
be fully understood. At the postsynaptic side of excita-
tory synapses, Ab-induced internalization of neurotrans-
mitter receptors has been considered to contribute to
reduced synaptic strength, but how Ab oligomers reduce
Figure 5 Spine-mitochondria association and its contribution to AMPAR trafficking.( a) A scoring system to assign different spine-mito
scores to each spine. The color image on the left shows a merged image of SEP-GluR1 highlighted spines (green) and mitochondria (red).
Different scores (0-3) were given to spines depending on their association and proximity to a mitochondrion. The schematic diagram illustrates
the scoring criteria, together with examples in magnified view. Analysis of several hundreds of spines from at least three batches of experiments
was performed for each condition and data are summarized in the bar graph in (b). Spines receiving spine-mito scores of 1-3 were considered
to be associated with mitochondria and used for calculating the percentage of spines associated with mitochondria (c). Single asterisk: p < 0.05;
double asterisk: p < 0.005; triple asterisks: p < 0.0005 (comparing to the corresponding control group, Student’s t-test).
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cell imaging to investigate the acute effects of soluble
Ab molecules on AMPAR trafficking at the postsynaptic
terminal and the potential contribution of mitochondria.
T h i ss t u d yw a sp a r t i a l l yi n s p i r e db yo u rp r e v i o u s
findings that soluble Ab molecules acutely inhibit
mitochondrial movement in hippocampal neurons, inde-
pendent of cell death and other drastic alternations
of cellular structures [34]. Given that mitochondria are
ac r u c i a lo r g a n e l l ef o re n e r g ys u p p l ya n di n t r a c e l l u l a r
Ca
2+ regulation, impaired mitochondrial movement
could disrupt their proper localization to synaptic sites,
Figure 6 Involvement of GSK3b in Ab impairment of AMPAR trafficking. Inhibition of GSK3b by a specific inhibitor SB415286 abolished
both Ab-induced loss of AMPARs from spine surface (a) and Ab-inhibition of AMPAR insertion during chemical LTP (b) as revealed by SEP-GluR1
imaging. Double asterisks: p < 0.005; triple asterisks: p < 0.0005 (comparing to the control, Student’s t-test).
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molecules. Taking advantage of the pH-dependent fluor-
escence emission of SEP-GluR1, we were able to quanti-
tatively analyze surface AMPARs, their trafficking
during cLTP, and the effects of Ab oligomers at single
spine level. Such an imaging-based approach has
allowed us to perform detailed analysis of changes asso-
ciated with individual spine. For instance, we were able
to show that Ab-induced removal of surface AMPARs
was not a consequence of spine loss, thus supporting a
relatively direct action of Ab on AMPAR trafficking
[24]. Furthermore, when combined with mitochondrial
imaging, we were able to reveal a positive correlation
between spine localization of mitochondria and AMAPR
trafficking. It is quite intriguing to see that local pre-
sence of mitochondria appears to favor AMPAR inser-
tion during synaptic potentiation and make them less
prone to Ab inhibition.
While our findings on Ab-induced removal of surface
AMPARs and inhibition of insertion during synaptic
potentiation were based on imaging of exogenously
expressed SEP-GluR1, we have performed surface stain-
ing using an anti-GluR1 antibody and confirmed the live
imaging results (unpublished results). Furthermore, our
results are consistent with previous studies employing
electrophysiology, immunostaining, and live-cell imaging
in which Ab was shown to reduce surface AMPARs
[24,37,46]. Ab-induced reduction of surface AMPARs
has been shown to share a common pathway with long
term depression (LTD) and to involve Ca
2+ signaling
through calcineurin for clathrin-mediated endocytosis of
AMPARs [24]. On the other hand, how Ab inhibits
AMPAR insertion during cLTP is unclear. Given that
AMPAR insertion during LTP depends on Ca
2+-depen-
dent exocytosis, Ab-elicited LTD pathway and elevated
AMPAR endocytosis could jeopardize LTP signaling cas-
cades to impair AMPAR insertion. While we considered
the increase in SEP-GluR1 fluorescence after TEA-cLTP
a result of increased AMPAR insertion, our data could
not rule out the possibility of decreased AMPAR inter-
nalization by TEA. Nonetheless, our study here has pro-
vided an intriguing possibility that Ab impairment of
mitochondrial trafficking might contribute to Ab inhibi-
tion on AMPARs. Localization of mitochondria to both
pre- and post-synaptic terminals has been observed and
likely plays a crucial role for synaptic transmission and
remodeling [31-33,47,48]. The rapid inhibition of mito-
chondrial movement observed previously [34,40] could
potentially disrupt the synaptic localization of mitochon-
dria to adversely affect synaptic functions. Indeed we
found that a brief exposure of hippocampal neurons to
Ab oligomers inhibited mitochondrial translocation into
spines induced by repetitive membrane depolarization.
Based on our correlation analysis, the lack of mitochon-
drial association appears to facilitate the inhibition of
AMPAR trafficking by Ab oligomers.
How do mitochondria contribute to AMPAR traffick-
ing? Potentially, the local production of ATP by mito-
chondria is required for vesicular fusion and insertion of
AMPARs to the postsynaptic surface. Mitochondria
could also be involved in local regulation of intracellular
Ca
2+ concentrations that are crucial for numerous
synaptic activities including synaptic transmission, LTP
and LTD, and endo/exocytotic trafficking of membrane
proteins. In particular, both LTP and LTD depend on
Ca
2+ signaling to control synaptic receptor trafficking:
the former requires a high Ca
2+ elevation for activating
CaMKII and downstream effectors for AMPA insertion
whereas the latter needs small Ca
2+ signals to activate
calcineurin phosphatase for AMAPR removal from the
surface [20,49,50]. The lack of mitochondria at the post-
synaptic terminal could alter local Ca
2+ signals to favor
the LTD pathway for AMPAR removal [24], thus
impeding the LTP-induced AMPAR insertion. Certainly,
many other synaptic activities, such as ATP-driven ion
pumps and local protein synthesis could also depend on
the local presence of mitochondria, which could be dis-
rupted by Ab oligomers. While Ab disruption of mito-
chondrial trafficking and localization to synapses might
not directly or solely cause AMPAR trafficking defects,
it could significantly contribute to postsynaptic defects
in coordination and synergy with other Ab-elicited
events (e.g. Ab induced internalization of synaptic
receptors). While direct evaluation of this mitochondrial
hypothesis requires selective disruption of mitochondrial
localization to spines or of specific mitochondrial func-
tion(s) at spines, our findings that inhibition of GSK3b
mitigate Ab impairment of trafficking of both AMPAR
and mitochondria suggest that these two events could
be linked in contributing to Ab-induced synaptic
inhibition.
In conclusion, our studies showed that soluble Ab oli-
gomers exert acute inhibition on the trafficking of both
mitochondria and synaptic receptors. The postsynapti-
cally localized mitochondria appear to be important for
the maintenance of AMPARs on postsynaptic surface as
well as for AMPAR insertion during synaptic potentia-
tion. Intriguingly, our correlation analysis suggests that
impairment of mitochondrial trafficking might contri-
bute to the adverse effects of Ab oligomers on AMPARs
on the postsynaptic surface. Future studies that employ
selective targeting of mitochondrial movement could
provide more definite answers regarding the precise role
of mitochondria in synaptic receptor trafficking, as well
as its precise contribution to synaptic defects in AD
brains.
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Cell culture and transfection
Hippocampal neurons from embryonic day 18 rats were
obtained according to the method described previously
[51]. Dissociated cells were plated in 35 mm glass bot-
tom culture dishes (Warner Instruments, Hamden, CT)
for culture and microscopy. The glass surface was pre-
treated with 100 μg/ml poly-D-lysine (Sigma, St. Louis,
MO) overnight and ~200,000 cells were plated in each
dish in Neurobasal medium containing B27 and Gluta-
max (Invitrogen). Cells were maintained in a 5% CO2
incubator at 37°C, with half of the culture medium
replaced with fresh Neurobasal medium every 3 d.
Before each imaging experiment, the medium was
replaced by Krebs’-Ringer’s buffer (KRB, in mM: 150
NaCl, 5 KCl, 2 CaCl2,1M g C l 2,1 0g l u c o s e ,a n d1 0
HEPES, pH 7.4) [52] or HEPES-buffered solution (HBS,
in mM: 140 NaCl, 5 KCl, 2 CaCl2,1 . 5M g C l 2,1 0g l u -
cose, and 25 HEPES, pH 7.4).
Hippocampal neurons were transfected using CalPhos
Mammalian Transfection Kit (Clontech, Mountain View,
CA). Neurons plated in 35 mm culture dishes at differ-
ent days in vitro (DIV) were used depending on the
experiments. Typically, we transfected the cells several
days before the imaging experiments to allow the
expression of various GFP-fusion or mutant proteins.
For experiments on mitochondrial transport, we typi-
cally transfected the neurons at DIV6-7 and performed
imaging on DIV8-9. For KCl depolarization experiments,
the transfection was performed on DIV12-13 and fol-
lowed by imaging on DIV14-15. For imaging studies on
AMPARs, the transfection was performed on DIV13-14
followed by imaging on DIV21-22 when mature synaptic
connections had been formed. The DNA constructs for
transfection were prepared by plasmid maxi kit (Qiagen,
Valencia, CA). The following constructs were used:
Mito-DsRed and Mito-GFP (generously provided by Dr.
Zheng Li at NIH/NIMH), pCi-SEP-GluR1 (a gift from
Dr. Roberto Malinow at University of California at San
Diego), EGFP-C1 and mOrange (Clontech). To create
Mito-mOrange, the mOrange coding sequence was sub-
cloned into Mito-GFP vector with green fluorescent
protein (GFP) sequence excised.
Ab preparation and treatment
We followed the previously published method to pre-
pare Ab oligomers for our experiments (Ab-O solution)
[53]. Ab1-42 was purchased from American Peptide
Company Inc (Sunnydale, CA) and dissolved in hexa-
fluoro-2-propanol (HFIP) and aliquoted to microfuge
tubes. HFIP was subsequently removed by evaporation
in a speed-vacuum and desiccated Ab aliquots were
stored at -20°C. To make Ab oligomer solution, each
Ab1-42 aliquot was dissolved in DMSO to make a 5 mM
stock solution. The solution was diluted to 100 μM with
KRB and kept at 4°C for 24 hr before use. To make an
Ab solution containing only monomers (Ab-M solu-
tion), Ab1-42 was directly dissolved in ddH2O at 1 mM,
diluted to 100 μM with KRB, and incubated at 37°C for
7d .A f t e r w a r d s ,t h eA b solution was centrifuged at
14,000 rpm for 60 min to remove Ab fibrils. The super-
natant was collected and passed through a 100 KD
molecular weight cut-off (MWCO) Amicon centrifugal
filter (Millipore) to further remove any large Ab aggre-
gates. Western blotting showed that this method
produced only Ab monomers (Figure 1b). The concen-
tration of Ab monomers in solution was determined
using Bradford Protein Assay (Bio-Rad) and adjusted to
the same concentration of Ab-O solution.
Bath application of Ab was achieved through a two-
step dilution procedure. First, the Ab stock solution was
diluted in KRB to twice the designated concentration
(2× working stock). The 2× working stock solution was
then gently added to and mixed with the bath saline of
the cells in an equal volume to reach the desired final
concentration. In a typical experiment, 1 ml of the 2×
stock solution was added to 1 ml of the bath solution in
the culture/imaging dish on the microscope stage.
Western blotting to detect Ab molecules
We used 4G8 anti-Ab antibody (Signet, Dedham, MA)
to perform western blotting to detect different forms of
Ab in our preparation. 80 ng Ab samples were added to
sample buffer with 50 mM DTT and heated at 85°C for
2 min. Samples were loaded and fractioned by PAGE on
10-20% Tris-Tricine gel (Invitrogen) and subsequently
transferred to nitrocellulose membranes. The membrane
was boiled for 10 min in PBS and blocked with 5% non-
fat dry milk in TBS with 0.05% Tween-20 (TBST) for 1
h at room temperature. The membrane was then incu-
bated with 4G8 antibody (1:1000) in blocking buffer
overnight at 4°C. Bound antibodies were detected by
HRP-conjugated secondary antibody, visualized by che-
miluminescence using ECL (Thermo Scientific, Rock-
ford, IL), and quantified using the gel analysis routine of
ImageJ software (NIH).
Live cell imaging of mitochondrial movement
Fluorescent time-lapse recordings were performed on an
inverted microscope (TE2000, Nikon) using a 40× N.A.
1.3 S-Fluor oil immersion objective with identical set-
tings between the control and experimental groups.
Time-lapse images were captured with a CCD camera
(SensiCam QE, Cooke Scientific) using the IPLab ima-
ging software (BD Biosciences). For imaging of mito-
chondrial transport, we typically recorded neurons at a
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CCD exposure at 50 ms exposure and 2 × 2 binning.
For each experiment, a population of neurons was
imaged for a 5 min control period before the application
of Ab molecules, followed by another 5 min time-lapse
recording at 30 min after Ab application. All the experi-
ments were performed on the microscope stage with the
35 mm dish housed in a temperature controlled cham-
ber (Warner Instruments, New Haven, CT) with the
temperature set at ~35°C. Quantification of moving
mitochondria was done by simply counting the number
of moving mitochondria in each 5 min time-lapse
sequence. A moving mitochondrion was defined as one
that moved more than a distance of twice its length
o v e rt h e5m i np e r i o d .S i n c en oc h a n g ei nt h et o t a l
mitochondrial number was observed [34], we normal-
ized the number of moving mitochondria in the 5-min
sequence against that before the Ab application. A value
of 100% indicates that same numbers of moving mito-
chondria were observed in both recording periods.
Confocal live-cell imaging on mitochondrial association
with dendritic spines and AMPAR trafficking
A Nikon C1 confocal on TE300 inverted microscope,
together with a 60× N.A.1.4 Plan Apo oil immersion
objective, was used for imaging. To be able to examine
all the spines at different focusing planes of a dendritic
segment, a z-stack of 10-12 images was taken on a
selected dendritic region followed by maximal intensity
projection to generate the 2-D image. For experiments
on KCl-stimulated mitochondria translocation into
spines, two-channel confocal imaging was performed on
neurons expressing EGFP and Mito-DsRed at DIV14-15.
To stimulate mitochondrial translocation into spines, we
used a previously described method of repetitive mem-
brane depolarization by KCl [33]. Here, 90 mM NaCl of
normal KRB was replaced with 90 mM KCl (hereafter
referred to as KCl-KRB) for membrane depolarization.
We performed 4 times of KCl-KRB exposure, each
exposure for 3 min and separated by 10 min recovery in
normal KRB. The same neurons were imaged before
and one hour after the 4× KCl stimulation to examine
the association of mitochondria with spines.
Similar confocal imaging was performed on hippocam-
pal neurons expressing SEP-GluR1 to study AMPAR
trafficking. Since SEP-GluR1 only emits strong fluores-
cence on cell surface and forms clusters as endogenous
AMPARs at postsynaptic terminals, we used an intensity
threshold that cut off the diffuse SEP-GluR1 fluores-
cence of dendritic shaft (considered as background) to
select postsynaptic receptor clusters that emitted sub-
stantial SEP-GluR1 signals, followed by quantification of
their number. Both thresholding and quantification were
done using ImageJ software. To examine the effect of
Ab molecules on surface AMPAR clusters, we acquired
images of the same dendritic region before and after Ab
exposure, followed by same thresholding and quantifica-
tion to determine the change in the number of spines
with SEP-GluR1 signals. For AMPAR insertion during
synaptic potentiation, we used a method involving a
brief exposure of cells to a potassium channel blocker
tetraethylammonium (TEA) to chemically induce poten-
tiation (cLTP) [39]. Here, we stimulated mature (DIV21)
hippocampal neurons expressing SEP-GluR1 with 25
mM TEA in a high-calcium and low-magnesium solu-
tion (in mM: 140 NaCl, 5 KCl, 5 CaCl2,0 . 1M g C l 2,1 0
glucose, and 25 HEPES, 25 TEA, pH 7.4) for 10 min.
Confocal live-cell imaging on the same dendritic regions
was performed before and after the stimulation to detect
changes in SEP-GluR1 fluorescence. Similar thresholding
and quantification were done on the two images (before
and after cLTP induction) to quantify the change in the
number of spines with SEP-GluR1 signals. For Ab
effects on AMPAR insertion during cLTP, we pre-trea-
ted the neurons with Ab oligomers for 30 min before
the cLTP induction by TEA.
Electrophysiology
Conventional whole cell patch-clamp recordings were
performed on the cell body of pyramidal hippocampal
neurons with voltage-clamped at -70 mV using an
EPC-7 patch-clamp amplifier (HEKA Instruments Inc.,
Bellmore, NY). Fire-polished borosilicate glass patch
pipettes had a resistance of 3-5 MΩ. Experiments were
conducted at room temperature (20-24°C). Since the
liquid junction potentials were small (< 2 mV), no cor-
rection was made. The standard pipette solution con-
tained (mM): 147 KCl, 2 KH2PO4,5T r i s - H C l ,2
EGTA, 10 HEPES, 4 Mg-ATP, pH 7.3 adjusted with
KOH, and osmolarity at 310-320 mOsmol
-1. The extra-
cellular recording solution contained (mM):128 NaCl,
5 KCl, 2 CaCl2,1M g C l 2,2 5H E P E S ,3 0g l u c o s e ,0 . 1
picrotoxin, pH 7.3 with NaOH, and osmolarity at 300-
310 mOsmol
-1.F o rm i n i a t u r eE P S C s ,0 . 5μMt e t r o d o -
toxin (TTX) was added to the extracellular recording
solution. To induce synaptic potentiation, a TEA solu-
tion (in mM: 80 NaCl, 20 KCl, 2 CaCl2,2 5T E A ,2 5
HEPES, 30 glucose, pH7.3 and 315 mOsmol
-1)w a s
perfused to the neurons. We typically recorded for
5-10 min before and after 10 min TEA treatment
(25 mM). During the TEA treatment, the patch-clamp
amplifier was switched to the current clamp mode
with the current set to zero for maximal synaptic sti-
mulation. The cell was re-clamped at -70 mV after
TEA washout. Recorded EPSCs were filtered at 2 kHz
before the analysis and presentation.
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